GRAHAM ANITA Z 4

What Happened

• Anita Z. Graham, EVP and Chief Human Resources Officer of Labcorp Holdings, was granted two types of equity awards on February 10, 2026: 4,100 employee stock options and 1,360 restricted stock units (RSUs). Each grant was reported as an award/derivative with an acquisition price of $0.00, meaning no cash was paid by the insider.
• The options are rights to buy shares under Labcorp’s 2025 Omnibus Incentive Plan; the RSUs represent contingent rights to receive common stock. These are compensation awards rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-02-10; filing date: 2026-02-12 (filed timely within the Form 4 reporting window).
• Price: $0.00 per share for both grants (no cash exchanged at grant).
• Vesting:
  • Options: vest in three equal annual installments beginning on the grant date (per footnote).
  • RSUs: vest in three equal annual installments beginning February 10, 2027.
• Shares owned after transaction: not specified in the filing.
• Footnotes of note:
  • F1: Options granted under the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
  • F2: Option vesting in three equal annual installments starting on the date shown.
  • F3: Each RSU equals the contingent right to one share.
  • F4: RSU vesting starts Feb 10, 2027 in three equal annual installments.
  • F5: The 1,360 figure reflects the aggregate RSUs held by the reporting person.

Context

• These transactions are grants of compensation (award/derivative), not purchases or sales; no immediate market purchase or sale occurred and no proceeds were received by the reporting person at grant.
• Options give a future right to buy shares (potential future purchase), while RSUs will convert to shares only as they vest. Such awards are common for executive compensation and do not by themselves indicate a change in insider sentiment about the company’s stock.